Journal of acquired immune deficiency syndromes (1999) · 2026
Longitudinal Performance of Self-Reported ART Adherence Compared With Tenofovir Diphosphate in Dried Blood Spots in South Africa.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ferraris Christopher M, D'Avanzo Paul A, Schiavoni Naomi Fireman, Knox Justin, Castillo-Mancilla Jose R, Anderson Peter L, Jennings Lauren, Orrell Catherine, Remien Robert H
Аннотация
BACKGROUND: Self-reported ART adherence is widely used in resource-limited settings but may not accurately reflect cumulative drug exposure. Few longitudinal studies in sub-Saharan Africa have directly compared self-report with pharmacologic adherence measures, specifically tenofovir diphosphate concentrations (TFV-DP) in dried blood spots (DBS).
SETTING: Observational cohort study conducted in four public-sector ART clinics in Cape Town, South Africa.
METHODS: We analyzed data from 250 adults living with HIV, followed monthly for 13 visits. Participants reported missed ART doses in the prior 30 days and provided DBS for TFV-DP concentration. Longitudinal associations between missed doses and TFV-DP were examined using generalized estimating equations. Receiver operating characteristic (ROC) analyses evaluated the ability of SR to identify low TFV-DP in DBS (<699 fmol/punch). Logistic GEE models assessed the association between self-reported nonadherence and low TFV-DP.
RESULTS: Most participants were female (78%), median age 34 years (IQR, 27-42). Median TFV-DP concentrations declined with increasing self-reported missed doses: 1206 (IQR, 943-1442), 1009 (IQR, 773-1364), and 859 (IQR, 542-1194) fmol/punch for 0, 1-2, and ≥3 missed doses, respectively. Each additional missed dose was associated with lower TFV-DP concentrations in adjusted models (β = -29.2 fmol/punch per missed dose; p<0.001). Reporting ≥2 missed doses was associated with higher odds of low TFV-DP in longitudinal models (adjusted OR 1.50; p<0.001).
CONCLUSIONS: Self-report missed doses correlated with TFV-DP concentrations over time but lacked sensitivity for detecting low drug exposure. Self-report remains pragmatic but may be optimized when paired with objective biomarkers to identify those at risk for treatment failure.
SETTING: Observational cohort study conducted in four public-sector ART clinics in Cape Town, South Africa.
METHODS: We analyzed data from 250 adults living with HIV, followed monthly for 13 visits. Participants reported missed ART doses in the prior 30 days and provided DBS for TFV-DP concentration. Longitudinal associations between missed doses and TFV-DP were examined using generalized estimating equations. Receiver operating characteristic (ROC) analyses evaluated the ability of SR to identify low TFV-DP in DBS (<699 fmol/punch). Logistic GEE models assessed the association between self-reported nonadherence and low TFV-DP.
RESULTS: Most participants were female (78%), median age 34 years (IQR, 27-42). Median TFV-DP concentrations declined with increasing self-reported missed doses: 1206 (IQR, 943-1442), 1009 (IQR, 773-1364), and 859 (IQR, 542-1194) fmol/punch for 0, 1-2, and ≥3 missed doses, respectively. Each additional missed dose was associated with lower TFV-DP concentrations in adjusted models (β = -29.2 fmol/punch per missed dose; p<0.001). Reporting ≥2 missed doses was associated with higher odds of low TFV-DP in longitudinal models (adjusted OR 1.50; p<0.001).
CONCLUSIONS: Self-report missed doses correlated with TFV-DP concentrations over time but lacked sensitivity for detecting low drug exposure. Self-report remains pragmatic but may be optimized when paired with objective biomarkers to identify those at risk for treatment failure.